Mechanisms involved in tissue-specific apopotosis regulated by glucocorticoids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 3-5, 2008, Pages 273-278

  Viegas, Luciana Rocha ^a,c   Hoijman, Esteban ^a,b   Beato, Miguel ^c   Pecci, Adali ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTO DE FISIOLOGÍA   (Argentina)

^c CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

Apoptosis; Bcl 2 family proteins; Glucocorticoids

Indexed keywords

CYCLIC AMP; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; PROTEIN BCL 2; PROTEIN BCL X; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; BREAST EPITHELIUM; CELL PROLIFERATION; ENDOMETRIUM; FIBROBLAST; HEMATOPOIETIC SYSTEM; LIVER CELL; MACROPHAGE; MONOCYTE; NONHUMAN; OVARY FOLLICLE CELL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; GLUCOCORTICOIDS; HUMANS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 43849089126     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.03.007     Document Type: Review

References (54)

1. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 5381 (1998) 1322-1326
2. Amsterdam A., and Sasson R. The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol. Cell. Endocrinol. 189 1-2 (2002) 1-9
3. Amsterdam A., Tajima K., and Sasson R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem. Pharmacol. 64 5-6 (2002) 843-850
4. Antonsson B., Montessuit S., Lauper S., Eskes R., and Martinou J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J. 345 Pt 2 (2000) 271-278
5. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 6 (1995) 851-857
6. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., and Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 4 (1993) 597-608
7. Bouillet P., and Strasser A. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J. Cell Sci. 115 Pt 8 (2002) 1567-1574
8. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., and Darnell Jr. J.E. Stat3 as an oncogene. Cell 98 3 (1999) 295-303
9. Broome H.E., Yu A.L., Diccianni M., Camitta B.M., Monia B.P., and Dean N.M. Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leuk. Res. 26 3 (2002) 311-316
10. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., and Van der Saag P.T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9 4 (1995) 401-412
11. Caron-Leslie L.A., Evans R.B., and Cidlowski J.A. Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J. 8 9 (1994) 639-645
12. Cory S., and Adams J.M. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2 9 (2002) 647-656
13. Chang T.C., Hung M.W., Jiang S.Y., Chu J.T., Chu L.L., and Tsai L.C. Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. FEBS Lett. 415 1 (1997) 11-15
14. Fang W., Rivard J.J., Mueller D.L., and Behrens T.W. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol. 153 10 (1994) 4388-4398
15. Feng Z., Marti A., Jehn B., Altermatt H.J., Chicaiza G., and Jaggi R. Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland. J. Cell Biol. 131 4 (1995) 1095-1103
16. Fujio Y., Kunisada K., Hirota H., Yamauchi-Takihara K., and Kishimoto T. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J. Clin. Invest. 99 12 (1997) 2898-2905
17. Gascoyne D.M., Kypta R.M., and Vivanco M.M. Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL. J. Biol. Chem. 278 20 (2003) 18022-18029
18. Glasgow J.N., Qiu J., Rassin D., Grafe M., Wood T., and Perez-Pol J.R. Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain. Neurochem. Res. 26 6 (2001) 647-659
19. Gorman A.M., Hirt U.A., Orrenius S., and Ceccatelli S. Dexamethasone pre-treatment interferes with apoptotic death in glioma cells. Neuroscience 96 2 (2000) 417-425
20. Grad J.M., Zeng X.R., and Boise L.H. Regulation of Bcl-xL: a little bit of this and a little bit of STAT. Curr. Opin. Oncol. 12 6 (2000) 543-549
21. Green D.R. Apoptotic pathways: the roads to ruin. Cell 94 6 (1998) 695-698
22. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 5381 (1998) 1309-1312
23. Grillot D.A., Gonzalez-Garcia M., Ekhterae D., Duan L., Inohara N., Ohta S., Seldin M.F., and Nunez G. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158 10 (1997) 4750-4757
24. Gross A., McDonnell J.M., and Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13 15 (1999) 1899-1911
25. Herr I., and Pfitzenmaier J. Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncol. 7 5 (2006) 425-430
26. Hillier S.G., and Tetsuka M. An anti-inflammatory role for glucocorticoids in the ovaries?. J. Reprod. Immunol. 39 1-2 (1998) 21-27
27. Hoijman E., Viegas L.R., Keller Sarmiento M.I., Rosenstein R.E., and Pecci A. Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Endocrinology 145 1 (2004) 418-425
28. Lepine S., Sulpice J.C., and Giraud F. Signaling pathways involved in glucocorticoid-induced apoptosis of thymocytes. Crit. Rev. Immunol. 25 4 (2005) 263-288
29. Lotem J., and Sachs L. Regulation of bcl-2, bcl-XL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ. 6 6 (1995) 647-653
30. Messmer U.K., Winkel G., Briner V.A., and Pfeilschifter J. Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways. Br. J. Pharmacol. 129 8 (2000) 1673-1683
31. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., and Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379 6566 (1996) 645-648
32. Miller A.L., Webb M.S., Copik A.J., Wang Y., Johnson B.H., Kumar R., and Thompson E.B. p38 mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol. 19 6 (2005) 1569-1583
33. Mok C.L., Gil-Gomez G., Williams O., Coles M., Taga S., Tolaini M., Norton T., Kioussis D., and Brady H.J. Bad can act as a key regulator of T cell apoptosis and T cell development. J. Exp. Med. 189 3 (1999) 575-586
34. Mund T., Gewies A., Schoenfeld N., Bauer M.K., and Grimm S. Spike, a novel BH3-only protein, regulates apoptosis at the endoplasmic reticulum. FASEB J. 17 6 (2003) 696-698
35. Nakajima H., Brindle P.K., Handa M., and Ihle J.N. Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription. EMBO J. 20 23 (2001) 6836-6844
36. Pecci A., Scholz A., Pelster D., and Beato M. Progestins prevent apoptosis in a rat endometrial cell line and increase the ratio of bcl-XL to bcl-XS. J. Biol. Chem. 272 18 (1997) 11791-11798
37. Pecci A., Viegas L.R., Baranao J.L., and Beato M. Promoter choice influences alternative splicing and determines the balance of isoforms expressed from the mouse bcl-X gene. J. Biol. Chem. 276 24 (2001) 21062-21069
38. Reed J.C. Apoptosis-targeted therapies for cancer. Cancer Cell 3 1 (2003) 17-22
39. Viegas L.R., Vicent G.P., Baranao J.L., Beato M., and Pecci A. Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter. J. Biol. Chem. (2006)
40. Saelzler M.P., Spackman C.C., Liu Y., Martinez L.C., Harris J.P., and Abe M.K. ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5. J. Biol. Chem. 281 24 (2006) 16821-16832
41. Schmitt E., Paquet C., Beauchemin M., and Bertrand R. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation. Oncogene 23 22 (2004) 3915-3931
42. Schorr K., and Furth P.A. Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res. 60 21 (2000) 5950-5953
43. Sevilla L., Aperlo C., Dulic V., Chambard J.C., Boutonnet C., Pasquier O., Pognonec P., and Boulukos K.E. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol. Cell. Biol. 19 4 (1999) 2624-2634
44. Shiraiwa N., Inohara N., Okada S., Yuzaki M., Shoji S., and Ohta S. An additional form of rat Bcl-x, Bcl-xbeta, generated by an unspliced RNA, promotes apoptosis in promyeloid cells. J. Biol. Chem. 271 22 (1996) 13258-13265
45. Tronche F., Opherk C., Moriggl R., Kellendonk C., Reimann A., Schwake L., Reichardt H.M., Stangl K., Gau D., Hoeflich A., Beug H., Schmid W., and Schutz G. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 18 5 (2004) 492-497
46. Tsujimoto Y., and Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 7 12 (2000) 1174-1181
47. Vicent G.P., Pecci A., Ghini A., Piwien-Pilipuk G., and Galigniana M.D. Differences in nuclear retention characteristics of agonist-activated glucocorticoid receptor may determine specific responses. Exp. Cell Res. 276 2 (2002) 142-154
48. Viegas L.R., Vicent G.P., Baranao J.L., Beato M., and Pecci A. Steroid hormones induce bcl-X gene expression through direct activation of distal promoter P4. J. Biol. Chem. 279 11 (2004) 9831-9839
49. Wada T., Pippin J.W., Marshall C.B., Griffin S.V., and Shankland S.J. Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins. J. Am. Soc. Nephrol. 16 9 (2005) 2615-2625
50. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., and Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139 5 (1997) 1281-1292
51. Yamamoto M., Fukuda K., Miura N., Suzuki R., Kido T., and Komatsu Y. Inhibition by dexamethasone of transforming growth factor beta1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction. Hepatology 27 4 (1998) 959-966
52. Yang X.F., Weber G.F., and Cantor H. A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7 5 (1997) 629-639
53. Yoshida M., Horinouchi S., and Beppu T. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17 5 (1995) 423-430
54. Yudt M.R., and Cidlowski J.A. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol. Endocrinol. 16 8 (2002) 1719-1726